Skip to main content
Tech.euFundingExplorerBeta

VivArt-X

Startup that aims to improve women’s lives after breast-conserving surgery

VivArt-X has raised €660k across 1 funding round from 4 investors, most recently a Pre-Seed round in Nov 2023. Based in Eindhoven, Netherlands; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€660k
€660,000
Funding rounds
1
Investors
4
distinct backers
Active since
2023-11
latest 2023-11

Funding by year

EUR raised per year
VivArt-X — funding by year — interactive chart.
Data table
VivArt-X — funding by year
2023€660k

Signals

High confidence
Raise-next likelihood4
base rate 24% for Pre-Seed
  • ▼ Past typical raise window
  • ▼ Low backer re-investment

Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2023-11-20Pre-Seed€660kBrabant Development Agency,Brabant Startup Fonds (BSF),Private Investors,TU/e ParticipationsView deal →

Related news

Similar companies

same sector or country

Global coverage: FundingData